Patents by Inventor Mark Cornell

Mark Cornell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240145820
    Abstract: Exemplary traction battery pack designs are described for use in electrified vehicles. An exemplary traction battery pack may include one or more thermal barrier structures. In some implementations, each thermal barrier structure may include both a heat exchanger portion for stabilizing a temperature of battery cells of the traction battery pack and a vacuum portion for isolating the battery cells and/or the heat exchanger portion from ambient conditions. In other implementations, the thermal barrier structure may include only the vacuum portion. The thermal barrier structure may be arranged to interface with a battery array of the traction battery pack and could be integrated as part of an enclosure assembly of the traction battery pack.
    Type: Application
    Filed: November 2, 2022
    Publication date: May 2, 2024
    Inventors: Larry Dean ELIE, Mark MEINHART, Jeremy SANTIAGO, Richard WERTH, John CORNELL
  • Publication number: 20240025979
    Abstract: The present invention relates to stable and low viscosity liquid pharmaceutical compositions comprising antibodies binding to human alpha synuclein and to methods for use of antibodies binding to human alpha synuclein for treating synucleinopathies or prodromal synucleinopathy, incl. suitable doses and/or dosing regimens. These antibodies for use in treatment of synucleinopathies or prodromal synucleinopathy may be formulated in the stable and low viscosity liquid pharmaceutical compositions of the invention.
    Type: Application
    Filed: June 26, 2023
    Publication date: January 25, 2024
    Inventors: Josefine NIELSEN SØDERBERG, Pekka Kallunki, Louise Buur, Frank Larsen, Henrik Rajesh Kumar Parshad, Anne Sofie Markussen, Mark Cornell Manning, Derrick Spencer Katayama, Magdalena Gauden, John Smith
  • Patent number: 11712821
    Abstract: The present invention related to an apparatus and method for the manufacturing of beverage capsules. The apparatus can preheat the material used to form the beverage material during the manufacturing process. The material and apparatus are particularly suitable for use in producing single serve beverage capsules from biodegradable materials.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: August 1, 2023
    Assignee: BIOME BIOPLASTICS LIMITED
    Inventors: Paul Robert Mines, Stephen William Baskerville, Mark Cornell
  • Patent number: 11534482
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: December 27, 2022
    Assignee: VIROPHARMA BIOLOGICS LLC
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • Patent number: 11364288
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: June 21, 2022
    Assignee: VIROPHARMA BIOLOGICS LLC
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • Patent number: 11300680
    Abstract: Disclosed in some examples are methods, systems, devices, and machine-readable media for 3D radar weather data rendering techniques. A computer-implemented method for 3D radar weather data rendering includes retrieving weather data from a weather radar. Gridded data is generated based on the weather data. The gridded data includes a uniform grid of cubes, where each of the cubes is associated with at least one weather parameter value of a plurality of weather parameter values corresponding to the weather data. A triangular mesh for a data grouping within the gridded data is extracted. An object file including vertices and faces associated with the triangular mesh is generated. The object file is communicated to a three-dimensional (3D) visualization system to present a 3D rendering of the object file.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: April 12, 2022
    Assignee: Raytheon Company
    Inventors: Mark A. Cornell, Rachel M. Phinney, Nicole A. Haffke, John Elkins, Alan M. Lee, Sabien D. Jarmin, Scott W. Nicholson
  • Publication number: 20220062414
    Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Inventors: Mark Cornell Manning, Zahra Shahrokh, Dave Nichols, Philip M Levesque, Ryan Erik Holcomb
  • Patent number: 11141479
    Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: October 12, 2021
    Assignee: KINIKSA PHARMACEUTICALS, LTD.
    Inventors: Mark Cornell Manning, Zahra Shahrokh, Dave Nichols, Philip M Levesque, Ryan Erik Holcomb
  • Publication number: 20210121536
    Abstract: Some embodiments provided herein relate to methods and pharmaceutical compositions comprising recombinant human surfactant protein D or active fragments thereof. Some such embodiments include solutions or suspensions, and lyophilized solid forms of recombinant human surfactant protein D or active fragments thereof.
    Type: Application
    Filed: March 27, 2019
    Publication date: April 29, 2021
    Inventors: Jan Susan Rosenbaum, Mark Cornell Manning, Derrick S. Katayama, Giovanni M. Pauletti, Shawn Grant, Ryan Holcomb
  • Publication number: 20210122090
    Abstract: The present invention related to an apparatus and method for the manufacturing of beverage capsules. The apparatus can preheat the material used to form the beverage material during the manufacturing process. The material and apparatus are particularly suitable for use in producing single serve beverage capsules from biodegradable materials.
    Type: Application
    Filed: March 20, 2018
    Publication date: April 29, 2021
    Inventors: Paul Robert MINES, Stephen William BASKERVILLE, Mark CORNELL
  • Publication number: 20210010988
    Abstract: Some embodiments of the methods and compositions provided herein include identifying and/or quantifying oligomeric species of surfactant protein-D (SP-D). Some embodiments include performing an asymmetric flow field-flow fractionation with multi-angle laser light scattering (AF4-MALLS) analysis on the SP-D.
    Type: Application
    Filed: March 27, 2019
    Publication date: January 14, 2021
    Inventors: Jan Susan Rosenbaum, Mark Cornell Manning, Ryan R. Manning
  • Publication number: 20200319335
    Abstract: Disclosed in some examples are methods, systems, devices, and machine-readable media for 3D radar weather data rendering techniques. A computer-implemented method for 3D radar weather data rendering includes retrieving weather data from a weather radar. Gridded data is generated based on the weather data. The gridded data includes a uniform grid of cubes, where each of the cubes is associated with at least one weather parameter value of a plurality of weather parameter values corresponding to the weather data. A triangular mesh for a data grouping within the gridded data is extracted. An object file including vertices and faces associated with the triangular mesh is generated. The object file is communicated to a three-dimensional (3D) visualization system to present a 3D rendering of the object file.
    Type: Application
    Filed: November 11, 2019
    Publication date: October 8, 2020
    Inventors: Mark A. Cornell, Rachel M. Phinney, Nicole A. Haffke, John Elkins, Alan M. Lee, Sabien D. Jarmin, Scott W. Nicholson
  • Publication number: 20200261556
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: October 2, 2019
    Publication date: August 20, 2020
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • Publication number: 20200061188
    Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
    Type: Application
    Filed: August 26, 2019
    Publication date: February 27, 2020
    Inventors: Mark Cornell Manning, Zahra Shahrokh, Dave Nichols, Philip M Levesque, Ryan Erik Holcomb
  • Publication number: 20200035028
    Abstract: Disclosed in some examples are methods, systems, devices, and machine-readable mediums for augmented reality (AR) Doppler weather radar (DWR) visualization application. A method is disclosed that includes retrieving weather radar data from a weather radar. The method may further include generating two (2) dimensional (D) polygons from the weather radar data, wherein the weather data comprises a three (3) D coordinate and a value indicating a weather condition, and wherein the 2D polygons are generated based on values of the value indicating the weather condition and an area of coverage. The method may further include sending the 2D polygons to an augmented-reality (AR) weather radar visualization system for the AR weather radar system to present a 3D rendering of the 2D polygons. The method may provide real-time weather 3D radar data that is animated.
    Type: Application
    Filed: April 2, 2019
    Publication date: January 30, 2020
    Inventors: Mark A. Cornell, Nicole A. Haffke, Sabien D. Jarmin, Rachel M. Phinney
  • Patent number: 10493149
    Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: December 3, 2019
    Assignee: Kiniksa Pharmaceuticals, Ltd.
    Inventors: Mark Cornell Manning, Zahra Shahrokh, Dave Nichols, Phillip M Levesque, Ryan Erik Holcomb
  • Patent number: 10391170
    Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: August 27, 2019
    Assignee: Kiniksa Pharmaceuticals, Ltd.
    Inventors: Mark Cornell Manning, Zahra Shahrokh, Dave Nichols, Phillip M Levesque, Ryan Erik Holcomb
  • Publication number: 20190160158
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficienty are disclosed.
    Type: Application
    Filed: September 5, 2018
    Publication date: May 30, 2019
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • Publication number: 20190160157
    Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.
    Type: Application
    Filed: August 2, 2018
    Publication date: May 30, 2019
    Inventors: Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb
  • Publication number: 20190054169
    Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.
    Type: Application
    Filed: November 2, 2018
    Publication date: February 21, 2019
    Inventors: Mark Cornell Manning, Zahra Shahrokh, Dave Nichols, Phillip M Levesque, Ryan Erik Holcomb